(NAII) Natural Alternatives - Ratings and Ratios

Natural Alternatives International, Inc. (NASDAQ:NAII) is a formulator, manufacturer, and marketer of nutritional supplements, operating through two primary segments: Private-Label Contract Manufacturing and Patent and Trademark Licensing. The company specializes in providing customized solutions for businesses in the health and wellness industry, including formulation development, clinical study support, and regulatory compliance. NAII manufactures products in various forms such as capsules, tablets, and powders, catering to a diverse range of distribution channels, including direct sales, e-commerce, and retail. Additionally, the company markets beta-alanine under the CarnoSyn and SR CarnoSyn brands. Founded in 1980, NAII is headquartered in Carlsbad, California, and operates with a strong focus on innovation and quality in the nutritional supplement sector.

From a technical perspective, NAIIs stock is currently trading below its key moving averages, with the SMA20 at 4.05 and SMA50 at 4.17, indicating potential bearish momentum. The SMA200 of 5.12 further suggests a longer-term downtrend. Average trading volume remains low at 5,124 shares over the past 20 days, with an ATR of 0.10, reflecting limited price volatility. The last price of 3.84 is below these averages, signaling weakness in the stock.

Fundamentally, NAII has a market cap of $24.73M, with a price-to-book ratio of 0.33 and a price-to-sales ratio of 0.20, indicating undervaluation relative to its assets and revenue. However, the companys return on equity (RoE) of -9.63% highlights profitability challenges. Over the next three months, based on the current technical setup and fundamental metrics, NAIIs stock is expected to remain under pressure, potentially trading sideways to slightly lower within a narrow range.